0001809245-20-000001.txt : 20200413 0001809245-20-000001.hdr.sgml : 20200413 20200413161011 ACCESSION NUMBER: 0001809245-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200413 DATE AS OF CHANGE: 20200413 EFFECTIVENESS DATE: 20200413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pyros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001809245 IRS NUMBER: 821881210 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-364840 FILM NUMBER: 20788911 BUSINESS ADDRESS: STREET 1: 333 W 39TH STREET STREET 2: SUITE 303 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 631-988-7154 MAIL ADDRESS: STREET 1: 333 W 39TH STREET STREET 2: SUITE 303 CITY: NEW YORK STATE: NY ZIP: 10018 D 1 primary_doc.xml X0708 D LIVE 0001809245 Pyros Pharmaceuticals, Inc. 333 W 39TH STREET SUITE 303 NEW YORK NY NEW YORK 10018 631-988-7154 DELAWARE Pyros Pharmaceuticals LLC None Corporation true 2019 Michael Smith c/o Pyros Pharmaceuticals, Inc. 333 W 39th Street, Suite 303 New York NY NEW YORK 10018 Director Edwin Urrutia c/o Pyros Pharmaceuticals, Inc. 333 W 39th Street, Suite 303 New York NY NEW YORK 10018 Director Other Decline to Disclose 06b false 2020-03-31 false true false 0 Paulson Investment Company, LLC 5670 None None 5335 Meadows Road Suite 465 Lake Oswego OR OREGON 97035 All States false 4000000 430000 3570000 false 6 565000 0 0 false Pyros Pharmaceuticals, Inc. /s/ Michael Smith Michael Smith Chief Executive Officer 2020-04-13